Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
3.665
+0.095 (2.66%)
At close: May 30, 2025, 4:00 PM
3.660
-0.005 (-0.14%)
After-hours: May 30, 2025, 4:04 PM EDT

Contineum Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
22.4721.9415.535.574.63
Short-Term Investments
168.24182.82109.6641.6764.37
Cash & Short-Term Investments
190.71204.76125.1947.2469
Cash Growth
61.75%63.56%165.01%-31.54%-
Prepaid Expenses
1.421.632.521.150.78
Total Current Assets
192.13206.39127.7148.3969.78
Property, Plant & Equipment
6.136.461.42.120.64
Other Long-Term Assets
001.280.130.1
Total Assets
198.26212.85130.3950.6470.52
Accounts Payable
3.651.810.640.430.66
Accrued Expenses
3.856.714.392.061.69
Current Portion of Long-Term Debt
---3.951.25
Current Portion of Leases
1.461.450.461.11-
Other Current Liabilities
----0.08
Total Current Liabilities
8.959.975.487.553.67
Long-Term Debt
----3.66
Long-Term Leases
4.554.810.110.79-
Other Long-Term Liabilities
--0.113.031.6
Total Liabilities
13.514.785.711.378.93
Common Stock
0.030.0300.010.01
Additional Paid-In Capital
317.96315.377.14.722.74
Retained Earnings
-133.39-117.4-75.14-97.86-73.61
Comprehensive Income & Other
0.170.070.11-0.08-0.04
Total Common Equity
184.77198.07-67.94-93.21-70.89
Shareholders' Equity
184.77198.07124.6839.2761.59
Total Liabilities & Equity
198.26212.85130.3950.6470.52
Total Debt
66.260.575.854.91
Net Cash (Debt)
184.71198.5124.6241.3964.1
Net Cash Growth
57.44%59.29%201.08%-35.42%-
Net Cash Per Share
7.3210.2636.7018.4530.39
Filing Date Shares Outstanding
25.8725.872.352.262.11
Total Common Shares Outstanding
25.8725.852.352.262.11
Working Capital
183.19196.41122.2240.8466.11
Book Value Per Share
7.147.66-28.91-41.25-33.61
Tangible Book Value
184.77198.07-67.94-93.21-70.89
Tangible Book Value Per Share
7.147.66-28.91-41.25-33.61
Machinery
-2.532.111.691.58
Leasehold Improvements
-0.180.050.020.02
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q